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is usually followed by a few side effects. Besides there is a grow-
ing tendency toward herbal medicines for treatment of vaginitis.
Antibacterial and antifungal effects of Zataria multiﬂora have
been demonstrated in vitro and in vivo. This study aimed to
compare therapeutic effects of Zataria Multiﬂora vaginal cream
and Metronidazole vaginal cream on bacterial vaginosis.
Material and Methods: This was a randomized clinical trial on
90 married women aged 18-40 affected by BV who attended for
treatment to gynaecology clinic of Shabih-Khani hospital. They
randomly divided to two groups of 45 participants. Diagnostic
criteria was Amsel’s criteria and gram-stain. Zataria Multiﬂora
vaginal cream or Metronidazole vaginal gel for 5 night usage
were prescribed to each group and after 2 to 7 days therapeutic
effects on participants’ complications and their Amsel criteria
were assessed. Data analysis was performed by McNemar and
Fisher exact tests.
Results: patients’ complication and their Amsel criteria were
signiﬁcantly decreased after treatment with Zataria Multiﬂora
or Metronidazole (P<0.05). Relative risk for unresponsiveness
to treatment with Zataria Multiﬂora, to unresponsiveness to
Metronidazole was 1.5 which was not signiﬁcant.
Conclusion: Therapeutic effects of Zataria Multiﬂora vaginal
cream is similar to Metronidazole vaginal gel on BV. Therefore
it could be an appropriate choice to BV treatment for those
interested in herbal medicines or affected by side-effects of
Metronidazole.
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Background: Standard Agglutination (SAT) and 2-mercap-
toethanol (2-ME) test are usually used for follow up of treated
cases of human brucellosis. The purpose of this study was to
monitor the levels of these tests after two years on clinically
cured cases of brucellosis.
Methods: From April 2003 to September 2008, 175 clinically
cured cases of brucellosis (103 males, 72 females) were evalu-
ated. Diagnosis of brucellosis was established with SAT ≥ 1:320
and 2ME ≥ 1:80 with clinical symptoms and signs compatible with
brucellosis. SAT and 2-ME were retested at the end of therapy
and every 3-months interval for two years. Serologic cure for SAT
or 2ME were considered when the titers decreased to ≤1:160 and
<1:80, respectively.
Results: The mean age of the patients was 31±13.5 years. Six,
12, 18 and 24 months after treatment, SAT titers ≥1:160 were
seen in 41 (23.4%), 22 (12.6%), 7 (4%) and in 6 (3.4%) cases,
respectively, whereas 2ME titers ≥1:80 were seen in 51 (29.1%),
24 (13.7%), 12 (6.9%) and 8 (4.6%) cases, respectively. Serologic
cure of SAT for patients with titers ≤1:640 was higher than that
of >1:640 (p=0.023). Serologic cure of 2ME for patients with
titers ≤1:320 was higher than that of >1:320 (p=0.04).
Conclusion: SAT and 2-ME may be in signiﬁcant titers in less than
5% of clinically treated cases after two years. Serologic cure for
both tests with lower titers were higher than that with higher
titers.
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Introduction: Rarely pathogenic in humans, the Leuconostoc
species is a gram-positive cocci belonging to the Streptococ-
caceae family. Unlike other gram-positive bacteria, Leuconostoc
species have a high resistance to vancomycin and only been re-
ported of peritoneal dialysis (PD) catheter infection in children.
This is the ﬁrst reported case of Leuconstac PD catheter infection
in adults.
Case Report: A 51-year-old man, with a signiﬁcant medical his-
tory of end-stage renal disease on peritoneal dialysis (PD) for 9.5
years, presented with abdominal pain, nausea, and vomiting. He
developed an infection with the PD catheter with methicillin-
susceptible staphylococcus aureus (MSSA) and treated with in-
travenous (IV) naﬁcillin, but refused catheter removal/change
due to religious reasons. He then developed diarrhea due to
a Clostridium difﬁcile (C. diff.) infection. The MSSA catheter
infection cleared and the C. diff. improved. The patient was put
on weekly IV Vancomycin suppression treatment for the MSSA
catheter site infection. However, three weeks later, the patient
developed peritonitis, with the PD ﬂuid noted to be hazy. Two
cultures were done one week apart and both conﬁrmed a Leucon-
stoc infection. The patient received oral penicillin followed by
intraperitoneal instillation of Cefazolin and Gentamicin, which
cleared the infection.
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PP-023 The inﬂuence of CMV infection on regulatory T
cell immunity of the host
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Objects: To study the inﬂuence of cytomegalovirus (CMV) infec-
tion on the number and function of regulatory T cells (Treg) and
the relationship between Treg and Th1, Th2, Tc1, Tc2 immunity.
Methods: A disseminating infected murine model was established
without using immunosuppressant. The infectious viral titer in
organs was quantiﬁed by plaque formation assay to estimate the
status of MCMV infection. The number and function of Treg and
the dynamic status of Th1, Th2, Tc1, Tc2 were evaluated by ﬂow
cytometry at different time point post infection.
Results: Histopathological damages were observed in the livers,
kidneys, lungs and hearts of the model. And Infectious virus
were not detected after 28d post infection. In chronic phase of
MCMV infection, the percentage of CD4+CD25+ cells and the ex-
pression of transcription factor Foxp3 both increased, which was
correlated with the reduction of Th1, Th2 and Tc1 percentage.
Conclusions: 1. A systemic MCMV infected model was success-
fully established, which provided a tool for exploring the immue
pathogenic mechanism of CMV infections. 2. MCMV could induce
the formation and activation of Treg. And the activated Treg
could suppress Th1, Th2, and Tc1 immunity during chronic phase,
which may be one of the mechanisms of the persistent infection
of CMV.
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0bjective: To prokaryotic expression the human X-box binding
protein 1-u (XBP1-u) recombinant plasmid, purify the protein
and immunize rabbit, to obtain polyclonal antibody against pro-
tein.
Methods: Transformed the recombinant plasmid pET32a-XBP1u
into host bacterium E. coli BL21 (DE3), then puriﬁed this protein,
